Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E, Ogawa H, Koyanagi R, Arashi H, Yamaguchi J, Matsui K, Hagiwara N. Kawada-Watanabe E, et al. Among authors: matsui k. J Cardiol. 2017 Mar;69(3):536-541. doi: 10.1016/j.jjcc.2016.05.002. Epub 2016 Jun 24. J Cardiol. 2017. PMID: 27349705 Free article. Clinical Trial.
Standard-dose statin therapy provides incremental clinical benefits in normocholesterolemic diabetic patients.
Kojima S, Sakamoto T, Ogawa H, Kitagawa A, Matsui K, Shimomura H, Kimura K, Ogata Y, Sakaino N; Multicenter Study for Aggressive Lipid-lowering Strategy by HMG-CoA Reductase Inhibitors Investigators. Kojima S, et al. Among authors: matsui k. Circ J. 2010 Apr;74(4):779-85. doi: 10.1253/circj.cj-09-0243. Epub 2010 Feb 17. Circ J. 2010. PMID: 20160396 Free article. Clinical Trial.
Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease.
Sakamoto T, Ogawa H, Nakao K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Canderstan for Prevention of Cardiovascular Events after CYPHER or TAXUS Coronary Stenting) investigators. Sakamoto T, et al. Among authors: matsui k. J Atheroscler Thromb. 2013;20(5):472-80. doi: 10.5551/jat.13870. Epub 2013 Mar 14. J Atheroscler Thromb. 2013. PMID: 23411616 Free article. Clinical Trial.
Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K, Sugiyama S, Sakamoto K, Tayama S, Nakamura S, Biwa T, Matsui K, Ogawa H; COMPACT-CAD Investigators. Kurogi K, et al. Among authors: matsui k. J Cardiol. 2013 Aug;62(2):87-94. doi: 10.1016/j.jjcc.2013.03.008. Epub 2013 May 11. J Cardiol. 2013. PMID: 23672789 Free article. Clinical Trial.
Endothelial function and cardiovascular events in chronic kidney disease.
Hirata Y, Sugiyama S, Yamamoto E, Matsuzawa Y, Akiyama E, Kusaka H, Fujisue K, Kurokawa H, Matsubara J, Sugamura K, Maeda H, Iwashita S, Jinnouchi H, Matsui K, Ogawa H. Hirata Y, et al. Among authors: matsui k. Int J Cardiol. 2014 May 15;173(3):481-6. doi: 10.1016/j.ijcard.2014.03.085. Epub 2014 Mar 20. Int J Cardiol. 2014. PMID: 24703800
Clinical outcomes of percutaneous coronary intervention (PCI) at hospital with or without onsite cardiac surgery backup.
Akasaka T, Hokimoto S, Oshima S, Nakao K, Fujimoto K, Miyao Y, Shimomura H, Tsunoda R, Hirose T, Kajiwara I, Matsumura T, Nakamura N, Yamamoto N, Koide S, Oka H, Morikami Y, Sakaino N, Kaikita K, Nakamura S, Matsui K, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators. Akasaka T, et al. Among authors: matsui k. Int J Cardiol. 2014 Oct 20;176(3):1385-7. doi: 10.1016/j.ijcard.2014.08.027. Epub 2014 Aug 10. Int J Cardiol. 2014. PMID: 25156861 No abstract available.
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Ono T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS study investigators. Tsujita K, et al. Among authors: matsui k. J Cardiol. 2015 Oct;66(4):353-8. doi: 10.1016/j.jjcc.2014.12.011. Epub 2015 Jan 7. J Cardiol. 2015. PMID: 25577723 Free article. Clinical Trial.
Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation　- The Kumamoto Intervention Conference Study (KICS) Registry.
Ishii M, Hokimoto S, Akasaka T, Fujimoto K, Miyao Y, Kaikita K, Oshima S, Nakao K, Shimomura H, Tsunoda R, Hirose T, Kajiwara I, Matsumura T, Nakamura N, Yamamoto N, Koide S, Oka H, Morikami Y, Sakaino N, Matsui K, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators. Ishii M, et al. Among authors: matsui k. Circ J. 2015;79(5):1115-24. doi: 10.1253/circj.CJ-14-0789. Epub 2015 Feb 24. Circ J. 2015. PMID: 25739954 Free article.
2,662 results